Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice

Cancer Research

Volumn 64, Issue 15, 2004, Pages 5378-5384

  Aharinejad, Seyedhossein ^a   Paulus, Patrick ^a   Sioud, Mouldy ^b   Hofmann, Michael ^a   Zins, Karin ^a   Schäfer, Romana ^a   Stanley, E Richard ^c   Abraham, Dietmar ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; COLONY STIMULATING FACTOR 1; COLONY STIMULATING FACTOR 1 RECEPTOR; COLONY STIMULATING FACTOR RECEPTOR; GELATINASE A; GENE PRODUCT; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN A;

ADOLESCENT; ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER INHIBITION; CANCER INVASION; CELL INFILTRATION; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MACROPHAGE INFILTRATION; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTO ONCOGENE; PROTO ONCOGENE C FMS; RECEPTOR BLOCKING; SURVIVAL; TUMOR ANGIOGENESIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR LYSATE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ANIMALS; CELL DIVISION; DOWN-REGULATION; ENDOTHELIAL CELLS; FEMALE; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 12; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGONUCLEOTIDES, ANTISENSE; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SURVIVAL RATE; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 3442901908     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0961     Document Type: Article

References (47)

1. Weir HK, Thun MJ, Hankey BF, et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (Bethesda) 2003;95:1276-99.
2. Weinberg RA. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. Cancer Res 1989;49:3713-21.
3. Russo J, Russo IH. The pathway of neoplastic transformation of human breast epithelial cells. Radiat Res 2001;155:151-4.
4. Xie B, Tsao SW, Wong YC. Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors. TGF-alpha, and EGF-R in mammary carcinogenesis. Breast Cancer Res Treat 1999;58:227-39.
5. Dickson C, Creer A, Fantl V. Mammary gland oncogenes as indicators of pathways important in mammary gland development. Oncogene 2000;19:1097-101.
6. Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature (Lond) 2001;411:375-9.
7. Kacinski B. Expression of CSF-1 and its receptor CSF-1R in non-hematopoietic neoplasms. Cancer Treat Res 2002;107:285-92.
8. Lin EY, Nguyen AV, Russel RG, Pollard JW. Colony-stimulating factor-1 promotes progression of mammary tumors to malignancy. J Exp Med 2001;193:727-39.
9. Mantovani A, Bottazzi B, Colotta F, Sozzant S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-70.
10. Ingber DE, Folkman J. How does extracellular matrix control capillary morphogenesis? Cell 1989;58:803-5.
11. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature (Lond) 1977;269:804-6.
12. Stetler-Stevenson WG. Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Investig 1999;103:1237-41.
13. Stanley ER, Guilbert LJ, Tushinski RJ, Bartelmez SH. CSF-1: a mononuclear phagocyte lineage-specific hemopoietic growth factor. J Cell Biochem 1983;21:151-9.
14. Sherr CJ, Rettenmier CW, Sacca R, et al. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1. Cell 1985;41:665-76.
15. Seelentag WK, Mermod JJ, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J 1987;6:2261-5.
16. Stanley ER. CSF-1. In: Oppenheim JJ, Feldmann M, editors. Cytokine reference: a compendium of cytokines and other mediators of host defence. London: Academic Press; 2000. p. 911-34.
17. op) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001;98:74-84.
18. Cecchini MG, Dominguez MG, Mocci S, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during post-natal development of the mouse. Development (Camb) 1994;120:1357-72.
19. Aharinejad S, Marks SC Jr, Böck P, et al. CSF-1 treatment promotes angiogenesis in the metaphysis of osteopetrotic (toothless, t1) rats. Bone 1995;16:315-24.
20. Eubank TD, Galloway M, Montague CM, Waldman WJ, Marsh CB. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. J Immunol 2003;171:2637-43.
21. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 1999;79:40-6.
22. Aharinejad S, Abraham D, Paulus P. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res 2002;62:5317-24.
23. Sorensen DR, Leirdal M, Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J Mol Biol 2003;327:761-6.
24. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc Natl Acad Sci USA 2001;98:9742-7.
25. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
26. Ruggeri B, Singh J, Gingrich D, et al. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antian-giogenic activity and antitumor efficacy in preclinical models. Cancer Res 2003;63:5978-91.
27. Abraham D, Hofbauer R, Schafer R, et al. Selective downregulation of VEGF-A (165), VEGF-R(1), and decreased capillary density in patients with dilative but not ischemic cardiomyopathy. Circ Res 2000;87:644-7.
28. Stanley ER. The macrophage colony stimulating factor, CSF-1. Methods Enzymol 1985;116:564-87.
29. Bartocci A, Pollard JW, Stanley ER. Regulation of colony-stimulating factor 1 during pregnancy. J Exp Med 1986;164:956-61.
30. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science (Wash DC) 2002;296:1046-9.
31. Gouon-Evans V, Rothenberg ME, Pollard JW. Postnatal mammary gland development requires macrophages and eosinophils. Development (Camb) 2000;127:2269-82.
32. Pollard JW, Hennighausen L. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci USA 1994;91:9312-6.
33. Sternlicht MD, Lochter A, Sympson CJ, et al. The stromal proteinase MMP3/ stromelysin-1 promotes mammary carcinogenesis. Cell 1999;98:137-46.
34. Ha HY, Moon HB, Nam MS, et al. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 2001;61:984-90.
35. Shiomi T, Okada Y. MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev 2003;22:145-52.
36. Fukumura D, Xavier R, Sugiura T, et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 1998;94:715-25.
37. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002;62:7042-9.
38. Kacinski BM. CSF-1 and its receptor in ovarian, endometrial and breast cancer. Ann Med 1995;27:79-85.
39. Sapi E, Kacinski BM. The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med 1999;220:1-8.
40. Kluger HM, Dolled-Filhart M, Rodov S, et al. Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin Cancer Res 2004;10:173-7.
41. Scholl SM, Pallud C, Beuvon F, et al. Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis. J Natl Cancer Inst (Bethesda) 1994;86:120-6.
42. Lewis CE, Leek R, Harris A, McGee JO. Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukocyte Biol 1995;57:747-51.
43. Webb SE, Pollard JW, Jones GE. Direct observation and quantification of macrophage chemoattraction to the growth factor CSF-1. J Cell Sci 1996;109:793-803.
44. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004;4:71-8.
45. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 2001;411:494-8.
46. Lin EY, Jones JG, Li P, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003;163:2113-26.
47. Sioud M. Therapeutic siRNAs. Trends Pharmacol Sci 2004;25:22-8.